Literature DB >> 31691904

Is Cystatin C Good Enough as a Biomarker for Vancomycin Dosing: A Pharmacokinetic Perspective.

Guo Yu1,2, Guo-Fu Li3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31691904     DOI： 10.1007/s13318-019-00587-3

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN： 0378-7966            Impact factor:   2.441


× No keyword cloud information.
  29 in total

1.  Estimating glomerular filtration rate by serum creatinine or/and cystatin C equations: An analysis of multi-centre Chinese subjects.

Authors:  Xiaoshuang Ye; Xun Liu; Dan Song; Xiaoxuan Zhang; Bei Zhu; Lu Wei; Xiaohua Pei; Jianqing Wu; Tanqi Lou; Weihong Zhao
Journal:  Nephrology (Carlton)       Date:  2016-05       Impact factor: 2.506

2.  Enzymatic assays for creatinine: time for action.

Authors:  Mauro Panteghini
Journal:  Clin Chem Lab Med       Date:  2008       Impact factor: 3.694

3.  Quantitative Estimation of Plasma Free Drug Fraction in Patients With Varying Degrees of Hepatic Impairment: A Methodological Evaluation.

Authors:  Guo-Fu Li; Guo Yu; Yanfei Li; Yi Zheng; Qing-Shan Zheng; Hartmut Derendorf
Journal:  J Pharm Sci       Date:  2018-03-06       Impact factor: 3.534

4.  Clearance of vancomycin during continuous infusion in Intensive Care Unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C.

Authors:  Martin G Kees; Justus W Hilpert; Carsten Gnewuch; Frieder Kees; Stephan Voegeler
Journal:  Int J Antimicrob Agents       Date:  2010-09-21       Impact factor: 5.283

5.  Serum cystatin C as a better marker of vancomycin clearance than serum creatinine in elderly patients.

Authors:  Go Okamoto; Tatsuichiro Sakamoto; Midori Kimura; Yoshiyuki Ukishima; Akihiro Sonoda; Noriko Mori; Yasuhiro Kato; Toshio Maeda; Yoshiyuki Kagawa
Journal:  Clin Biochem       Date:  2007-01-26       Impact factor: 3.281

6.  A population pharmacokinetic model of vancomycin for dose individualization based on serum cystatin C as a marker of renal function.

Authors:  Tao-Tao Liu; Hui-Mei Pang; Li Jing; Wen-Xing Wei; Xiao-Ling Qin; Qing Guo; Hua Lu; Dao-Hai Cheng; Wei-Zhe Jiang
Journal:  J Pharm Pharmacol       Date:  2019-03-14       Impact factor: 3.765

7.  Population pharmacokinetic analysis of vancomycin using serum cystatin C as a marker of renal function.

Authors:  Akihiro Tanaka; Tetsuya Aiba; Takashi Otsuka; Katsuya Suemaru; Tatsuya Nishimiya; Tomoyoshi Inoue; Mitsuharu Murase; Yuji Kurosaki; Hiroaki Araki
Journal:  Antimicrob Agents Chemother       Date:  2009-11-23       Impact factor: 5.191

8.  Creatinine or cystatin C - which is a better index of renal function in morbid obesity?

Authors:  P Mysliwiec; P Jasiewicz; H R Hady; B Choromanska; B Mroczko; H Mysliwiec; A Siemiatkowski; J Dadan; M Szmitkowski
Journal:  Adv Med Sci       Date:  2013       Impact factor: 3.287

9.  Comparison of equations with estimate renal function to predict serum vancomycin concentration in patients with spinal cord injury--does the use of cystatin C improve accuracy?

Authors:  Douglas D DeCarolis; Joey G Thorson; Rebecca A Marraffa; Megan A Clairmont; Michael A Kuskowski
Journal:  Ther Drug Monit       Date:  2014-10       Impact factor: 3.681

10.  Usefulness of serum cystatin C to determine the dose of vancomycin in neonate.

Authors:  Jeong Eun Shin; Soon Min Lee; Ho Seon Eun; Min Soo Park; Kook In Park; Ran Namgung
Journal:  Korean J Pediatr       Date:  2015-11-22
View more
  1 in total

1.  Diagnostic Value of Multiple Serum Biomarkers for Vancomycin-Induced Kidney Injury.

Authors:  Sang-Mi Kim; Hyun-Seung Lee; Min-Ji Kim; Hyung-Doo Park; Soo-Youn Lee
Journal:  J Clin Med       Date:  2021-10-27       Impact factor: 4.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.